GoodRx Holdings (GDRX) stock forecast for 2021. Forecast tables and graphs.

GoodRx Holdings (GDRX) stock forecast for 2021

The forecast has been updated: October 19, 2021 14:04


GoodRx Holdings stock price online today

Analyst Target Price

43.79

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell GoodRx Holdings stock stock today? What is the projected target price level for 2021? How much will it cost in 2021? GoodRx Holdings stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2021.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $43.79 target price for GoodRx Holdings stock stock.

Today 200 Day Moving Average is the support level (37.03 $).

50 Day Moving Average is the resistance level (42.42 $).




GDRX Forecast for 2021

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Nov 43.42 40.45 44.73 9.55 %
Dec 45.19 44.06 49.37 10.77 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GoodRx Holdings stock.


GoodRx Holdings overview

GoodRx Holdings Address

233 WILSHIRE BLVD., SUITE 990, SANTA MONICA, CA, US

Market Capitalization

16 783 048 000 $

EBITDA

79 103 000

PE Ratio

None

PEG Ratio

None

Dividend Per Share

None

Dividend Yield

None

EPS

-0.815

Quarterly Earnings Growth YOY

-0.071

Quarterly Revenue Growth YOY

0.433

Trailing PE

0

Forward PE

74.63

EV To Revenue

25.36

EV To EBITDA

238.21

52 Week High

59.67

52 Week Low

26.66

50 Day Moving Average

42.42

200 Day Moving Average

37.03

Shares Outstanding

75429000

Shares Float

65205000

Shares Short Prior Month

15947300

Short Ratio

8.41

Percent Insiders

8.1

Percent Institutions

88.16

GoodRx Holdings stock forecast for this year


GoodRx Holdings stock forecast for Nov 2021.
Estimated Average Forecasted GoodRx Holdings Price: 43.42. Positive monthly dynamics of the instrument is expected with 9.553% volatility is expected.

Pessimistic forecast: 40.45

Optimistic: 44.73


GoodRx Holdings stock forecast for Dec 2021.
Estimated Average Forecasted GoodRx Holdings Price: 45.19. Positive monthly dynamics of the instrument is expected with 10.765% volatility is expected.

Pessimistic forecast: 44.06

Optimistic: 49.37



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 126.72 (22.10.2021) 1.34 %
AbbVie Inc.
ABBV 109.14 (22.10.2021) 0.35 %
Aeterna Zentaris Inc.
AEZS 0.5869 (22.10.2021) -3.55 %
Allakos Inc.
ALLK 108.16 (22.10.2021) 4.38 %
Allogene Therapeutics, Inc.
ALLO 15.82 (22.10.2021) -0.75 %
Amgen Inc.
AMGN 209.24 (22.10.2021) 0.12 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 16.03 (22.10.2021) 1.39 %
Aurora Cannabis Inc.
ACB 7.07 (22.10.2021) -4.07 %
Becton Dickinson and Company
BDX 247.09 (22.10.2021) 0.25 %
Biogen Inc.
BIIB 264.8 (22.10.2021) -2.00 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 139.9 (22.10.2021) 2.21 %
BioNTech SE
BNTX 278.34 (22.10.2021) -2.80 %
bluebird bio, Inc.
BLUE 20.8 (22.10.2021) 2.01 %
Boston Scientific Corp.
BSX 44.84 (22.10.2021) -0.07 %
Bristol-Myers Squibb Company
BMY 57.6 (22.10.2021) -0.36 %
Canopy Growth Corp.
CGC 13.38 (22.10.2021) -4.70 %
Castle Biosciences, Inc.
CSTL 62.73 (22.10.2021) -0.29 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 243.75 (22.10.2021) 1.07 %
Emergent BioSolutions Inc.
EBS 49.85 (22.10.2021) -1.46 %
Exelixis, Inc.
EXEL 21.4 (22.10.2021) 0.33 %
G1 Therapeutics, Inc.
GTHX 13.61 (22.10.2021) 2.64 %
Gilead Sciences, Inc.
GILD 67.24 (22.10.2021) 0.37 %
GlaxoSmithKline plc
GSK 39.77 (22.10.2021) 0.56 %
GoodRx Holdings, Inc.
GDRX 47.16 (22.10.2021) 0.34 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 65.79 (22.10.2021) -0.12 %
Inovio Pharmaceuticals, Inc.
INO 6.74 (22.10.2021) -4.26 %
Johnson & Johnson
JNJ 163.72 (22.10.2021) 0.20 %
Medtronic plc.
MDT 123.09 (22.10.2021) 1.18 %
Merck & Co., Inc.
MRK 81.15 (22.10.2021) -0.02 %
Moderna, Inc.
MRNA 326.54 (22.10.2021) -3.84 %
Novartis AG
NVS 84.92 (22.10.2021) 0.30 %
Novavax, Inc.
NVAX 134.56 (22.10.2021) -3.05 %
ObsEva SA
OBSV 2.65 (22.10.2021) 1.53 %
OrganiGram Holdings Inc.
OGI 2.34 (22.10.2021) -4.10 %
Pfizer Inc.
PFE 43.16 (22.10.2021) 0.70 %
Regeneron Pharmaceuticals, Inc.
REGN 572.36 (22.10.2021) 0.53 %
Sanofi
SNY 49.92 (22.10.2021) 1.44 %
Schrodinger, Inc.
SDGR 52.67 (22.10.2021) -5.95 %
Senseonics Holdings, Inc.
SENS 3.49 (22.10.2021) -2.51 %
Sorrento Therapeutics, Inc.
SRNE 6.45 (22.10.2021) -1.68 %
Stryker Corp.
SYK 275.73 (22.10.2021) -0.26 %
Sundial Growers Inc.
SNDL 0.6595 (22.10.2021) -5.58 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10.13 (22.10.2021) -0.10 %
Thermo Fisher Scientific Inc.
TMO 611.96 (22.10.2021) 0.58 %
Tilray, Inc.
TLRY 11.08 (22.10.2021) -4.15 %
UnitedHealth Group, Inc.
UNH 449.16 (22.10.2021) 1.56 %
Veeva Systems Inc.
VEEV 320.56 (22.10.2021) -1.44 %
Zomedica Corp.
ZOM 0.499 (22.10.2021) -2.12 %
Zynerba Pharmaceuticals, Inc.
ZYNE 3.87 (22.10.2021) -6.30 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.